CIK 0001850270 · <br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,067,773
- in 1 filing
Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | Legorreta Pablo G. Director | Other disposition | −3,823,996 | 22,617,909 | ||
| 2025-06-03 | Legorreta Pablo G. Director | Conversion · Class B Ordinary Shares | −3,823,996 | 84,283,430 | ||
| 2025-06-03 | Legorreta Pablo G. Director | Conversion · Common Units in ProKidney LP | −3,823,996 | 84,283,430 | ||
| 2025-05-29 | Legorreta Pablo G. Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | Sinha Uma Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | Pereira Brian JG Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | Jimenez Santos Jose Ignacio Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | Fox Jennifer A. Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | DOYLE WILLIAM F Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-05-29 | Lotvin Alan Director | Grant or award · Director stock option (right to buy) | +125,862 | 125,862 | ||
| 2025-04-22 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +387,393 | $0.71 | $276K | 73,842,723 |
| 2025-04-17 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +25,000 | $0.75 | $19K | 73,455,330 |
| 2025-04-16 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +100,000 | $0.75 | $75K | 73,430,330 |
| 2025-04-15 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +468,000 | $0.70 | $326K | 73,330,330 |
| 2025-04-14 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +268,105 | $0.73 | $195K | 72,862,330 |
| 2025-04-11 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +1,900 | $0.61 | $1K | 72,594,225 |
| 2025-04-10 | Control Empresarial de Capitales S.A. de C.V. 10% owner | Purchase | +1,032,218 | $0.61 | $628K | 72,592,325 |
| 2025-03-01 | Culleton Bruce Chief Executive Officer | Grant or award · Employee stock option (right to buy) | +1,796,000 | 1,796,000 | ||
| 2025-03-01 | Weber Darin J. Chief Regulatory Officer | Grant or award · Employee stock option (right to buy) | +450,000 | 450,000 | ||
| 2025-03-01 | Girolamo Todd C Chief Legal Officer | Grant or award · Employee stock option (right to buy) | +650,000 | 650,000 |
Page 3 of 9 · 179 trades